Podcasts about Drug

In this jaw-dropping episode , we sit down with George Day — one of the most prolific yet largely unknown drug kingpins in American history. Raised in Washington, DC, George was literally born into the drug trade. By age six, he was traveling across the border with his father, helping smuggle hundreds of pounds of marijuana hidden inside a Winnebago. As he grew older, his life spiraled deeper into the underworld — from trimming weed in Mexico to handling massive cash pickups and negotiating with Colombian suppliers before he was even a teenager. After his father's sudden death, George found himself — at just 11 years old — sitting on a multimillion-dollar drug ledger, forced to navigate dangerous debts, cartel relationships, and violent street politics. What followed was the rise of a cocaine empire that eventually stretched across all 50 states… and ultimately led to a life sentence plus 90 years in federal prison. This is Part 1 of an unbelievable story about family, survival, crime, and the realities of growing up inside America's drug economy.

This episode covers: • Microplastics Are Destroying Male Fertility and Metabolism New research is putting microplastics in a category most men still are not taking seriously: direct reproductive and hormone risk. A 2024 study detected microplastics in every human testicle examined, with polyethylene and PVC among the most common polymers. PVC is especially relevant because it's often tied to chemical additives that can disrupt endocrine signaling. The broader body of evidence points to micro- and nanoplastics crossing barriers like the blood–testis barrier, driving inflammation and oxidative stress in the testes, and showing associations with impaired sperm quality and hormone disruption. The longevity move here is reducing overall load: better water filtration, less plastic food contact, no heating food in plastic, fewer packaged foods, and taking indoor dust and air quality seriously, especially for men thinking about fertility now or hormone resilience over decades. • Sources: – Study (PubMed): https://pubmed.ncbi.nlm.nih.gov/38745431/ – Coverage: https://people.com/microplastics-in-every-human-testicle-infertility-8651215 • Fear of Aging Is Linked to Faster Biological Aging A new study ties aging anxiety to measurable acceleration in biological aging using DNA methylation clocks. People who reported more worry and negative beliefs about aging showed faster epigenetic aging signals, and the molecular differences clustered around stress and inflammatory pathways. In plain terms, chronic threat-mode thinking around aging maps onto biology that looks older on the clocks. For a longevity audience, this is a practical reminder that mental inputs affect physiological outputs. If your day-to-day mindset is constant pressure and decline narratives, that can show up downstream in stress biology and inflammatory tone. A smarter play is building a longevity framework around function, strength, purpose, and community, alongside the usual pillars like sleep, training, and metabolic health. • Source: https://medicalxpress.com/news/2026-02-older-links-health-faster-epigenetic.html • Additional source: https://www.nyu.edu/about/news-publications/news/2026/february/aging-anxiety.html • Retatrutide, the Triple-Agonist Weight-Loss Drug Pushing Bariatric-Level Results Retatrutide is a triple agonist that targets GLP-1, GIP, and glucagon receptors, and the weight-loss numbers being reported are massive. In a 68-week study in people with obesity and knee osteoarthritis, the highest dose group averaged about 28.7% body-weight loss, along with meaningful improvements in knee pain and function. This is the next phase of incretin medicine: multi-agonist drugs that can move body weight by a quarter or more. For biohackers, the performance and longevity angle is implementation: preserving lean mass through resistance training, hitting protein targets, monitoring micronutrients, and building a maintenance plan that doesn't collapse the moment the drug stops. The upside is cardiometabolic risk reduction at scale. The key is running it with structure. • Sources: – Eli Lilly release: https://investor.lilly.com/news-releases/news-release-details/lillys-triple-agonist-retatrutide-delivered-weight-loss-average – Coverage: https://nypost.com/2026/02/18/health/people-dropped-out-of-retatrutide-trial-for-losing-too-much-weight/ – Background: https://news.harvard.edu/gazette/story/2026/02/whats-next-for-glp-1s/ • AI Can Predict 130 Diseases From a Single Night of Sleep Stanford's SleepFM project shows how much long-horizon health information is encoded in sleep. Researchers trained a foundation model on roughly 585,000 hours of clinical polysomnography data from about 65,000 people. From a single night of sleep study signals, the model could estimate risk for 130 conditions, including dementia, heart attack, heart failure, chronic kidney disease, stroke, atrial fibrillation, and all-cause mortality, and it generalized across cohorts better than simple demographic baselines. The big implication is that sleep architecture and micro-patterns (stage distribution, fragmentation, breathing stability, micro-arousals) function like a dense biomarker stream for systemic aging and disease risk. Expect better sensors and more validated risk dashboards over time. Right now, this is another reason to treat sleep as a core diagnostic pillar, not just a recovery habit. • Sources: – Stanford Medicine: https://med.stanford.edu/news/all-news/2026/01/ai-sleep-disease.html – Paper (Nature Medicine): https://www.nature.com/articles/s41591-025-04133-4 • Living at High Altitude May Protect Against Diabetes by Turning Red Blood Cells Into Glucose Sinks For years, population data has suggested lower diabetes rates at higher elevations. New mechanistic work is pointing to a surprising driver: red blood cells changing how they handle glucose under low oxygen conditions. In hypoxia, red blood cells can behave like glucose sinks, pulling more sugar out of circulation and improving glucose tolerance, which may help explain the protective association seen at altitude. The downstream potential is a new class of altitude-mimetic approaches that target erythrocyte metabolism as a glucose lever, separate from appetite suppression or classic diabetes pathways. For biohackers, it expands the metabolic toolkit and reinforces that oxygen environment and blood physiology matter more than we've given them credit for. • Source: https://medicalxpress.com/news/2026-02-red-blood-cells-sugar-high.html • Dietary Supplement Regulatory Uniformity Act and the Future of Supplement Access A proposed bill is aiming to stop states from layering extra rules on dietary supplements beyond federal law, creating one national standard instead of a patchwork of state-by-state restrictions. Industry groups are supporting it as a way to reduce confusion and compliance chaos, especially as some states explore age limits or special labeling requirements for certain supplement categories. The strategic implication for biohackers is that regulation shapes access. Uniformity can stabilize availability, but it also raises the stakes of federal decisions on controversial ingredients. This is one of those policy stories that quietly determines what stays on shelves, what disappears, and how much innovation survives in the supplement space. • Sources: – NutritionInsight: https://www.nutritioninsight.com/news/npa-crn-supplements-us-fda-legislation.html – Congressional release: https://langworthy.house.gov/media/press-releases/congressman-langworthy-introduces-dietary-supplement-regulatory-uniformity-act – NutraIngredients: https://www.nutraingredients.com/Article/2026/02/05/new-bill-aims-to-end-state-supplement-regulations/ All source links are provided for direct access to the original reporting and research. New episodes every Tuesday, Thursday, Friday, and Sunday. Keywords: microplastics male fertility, microplastics testosterone decline, blood–testis barrier toxins, endocrine disruption plastics, sperm count microplastics, epigenetic age acceleration, fear of aging methylation, biological aging mindset, stress inflammation aging, retatrutide triple agonist, GLP-1 GIP glucagon weight loss, incretin drugs obesity treatment, muscle preservation on GLP-1, SleepFM AI model, sleep disease prediction, polysomnography risk scoring, dementia risk sleep data, altitude diabetes protection, hypoxia glucose metabolism, red blood cells glucose uptake, altitude mimetic therapy, Dietary Supplement Regulatory Uniformity Act, supplement regulation federal preemption, FDA supplement policy, biohacking news longevity, metabolic health optimization Thank you to our sponsors! - HeartMath | Go to https://www.heartmath.com/dave to save 15% off. - BrainTap | Go to http://braintap.com/dave to get $100 off the BrainTap Power Bundle. Resources: • Get My 2026 Biohacking Trends Report: https://daveasprey.com/2026-biohacking-trends-report/ • Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today. • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Join My Substack (Live Access To Podcast Recordings): https://substack.daveasprey.com/ • Upgrade Labs: https://upgradelabs.com Timestamps: 0:00 – Intro 0:19 – Story 1: Microplastics in Testicles 1:44 – Story 2: Fear of Aging Accelerates Aging 3:30 – Story 3: Retatrutide Weight Loss Drug 4:42 – Story 4: Sleep Predicts Disease Risk 6:34 – Story 5: High Altitude & Diabetes 7:57 – Story 6: Supplement Regulation Bill 9:16 – Weekly Summary 10:51 – Outro See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

“That's the thing that's maybe getting lost in some of the fear mongering around it is that, it's not the easy way out. It doesn't mean that you don't have to do the work. It means that when you do the work, the work actually makes the difference.” —Aja BeckettFood noise can sit in the back of the mind all day, from planning the next meal at breakfast to carrying quiet shame after every snack. In a culture that moralizes weight and labels bodies as failures, real medical treatment for obesity often gets buried under hot takes about shortcuts and cheating. This conversation brings the lived reality of GLP-1 medication into the light, with honesty about both relief and responsibility.Aja Beckett shares decades of struggling with obesity, endless diets, and that constant mental hum around food, then walks through how starting a GLP-1 weight loss drug shifted cravings, energy, and hope. Her experience led to building Shotsy, a companion app that tracks doses, side effects, and progress for people on GLP-1 medications.Press play to hear how this new class of medications is reshaping daily life, mindset, and digital tools around obesity care, including:What GLP-1 drugs like Ozempic and Wegovy actually do in the bodyThe difference between “food noise” and genuine hungerWhy weight loss drugs are not a lazy shortcut or moral failureHow mental health, cravings, and compulsive behaviors often change on GLP-1sThe cost, access, and safety concerns around weight loss injections and pillsHow a GLP-1 tracking app grew from one person's spreadsheet into a fast-growing productWhat long-term obesity treatment and maintenance can realistically look likeConnect with Heather:WebsiteLinkedInInstagramFacebookYouTubeEpisode Highlights:01:11 Meet Aja Beckett: Founder of Shotsy & GLP‑1 Success Story04:43 Discovering Ozempic & a Difficult Doctor's Visit07:35 Beyond Weight Loss: GLP‑1, Mental Health & Addictive Behaviors10:43 Losing 90 Pounds: From Obesity to Healthy BMI13:30 Do You Still Have to Eat Healthy & Work Out on GLP‑1?16:21 When the Food Noise Stops: First Days on GLP‑119:37 Super Bowl Snacks, Portion Control & Balanced Indulgence22:12 Body Dysmorphia in Bigger & Smaller Bodies26:00 Safety vs Affordability: Regulation, Shortages & DIY Risks32:09 Introducing Shotsy: The GLP‑1 Companion App Idea39:50 Why Tools Like Shotsy Matter for Accountability & Tracking42:21 GLP‑1 Isn't the “Easy Way Out”: Doing the Work & Seeing ResultsResources:

This episode explores tadalafil (Cialis) as a potential longevity drug, though no randomized human trials prove it extends lifespan. Cialis works by blocking PDE5, enhancing nitric oxide signaling, and improving blood flow through vasodilation. Originally approved for pulmonary hypertension, it's also used for erectile dysfunction and BPH. Its 36-hour half-life makes it superior to Viagra for continuous longevity effects.   The host frames vascular aging and endothelial dysfunction as key drivers of age-related diseases (heart disease, stroke, dementia, kidney disease). Observational data shows Cialis users have 44% lower mortality, fewer cardiovascular events, reduced dementia risk, and lower mortality in diabetics. Additional benefits include improved cardiac function, reduced infarct size, arrhythmia suppression, and regression of left ventricular hypertrophy. A 2024 meta-analysis found it lowers hemoglobin A1C, possibly via improved microvascular perfusion, insulin sensitivity, and mitochondrial function.   Cialis crosses the blood-brain barrier and may improve neurovascular coupling and hippocampal plasticity, potentially benefiting those with or at risk of dementia. Safety is generally good with long-term daily use (2.5–5 mg), though cautions include avoiding use with nitrates, low blood pressure, or certain retinal disorders. Common side effects are headache, nasal congestion, and acid reflux. The host recommends consulting a doctor and references potential synergy with telmisartan.   Tadalafil (Cialis) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a604008.html](https://medlineplus.gov/druginfo/meds/a604008.html) Sildenafil (Viagra) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a699015.html](https://medlineplus.gov/druginfo/meds/a699015.html)   Key mechanisms mentioned Nitric Oxide (NO) — NCBI Bookshelf: [https://www.ncbi.nlm.nih.gov/books/NBK554485/](https://www.ncbi.nlm.nih.gov/books/NBK554485/) Cyclic GMP (cGMP) — NCBI Bookshelf: [https://www.ncbi.nlm.nih.gov/books/NBK542234/](https://www.ncbi.nlm.nih.gov/books/NBK542234/)   Conditions mentioned in the episode Benign Prostatic Hyperplasia (BPH) — MedlinePlus: [https://medlineplus.gov/benignprostatichyperplasia.html](https://medlineplus.gov/benignprostatichyperplasia.html) Pulmonary Arterial Hypertension (PAH) — MedlinePlus: [https://medlineplus.gov/pulmonaryhypertension.html](https://medlineplus.gov/pulmonaryhypertension.html)   Blood pressure drug mentioned Telmisartan — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a601249.html](https://medlineplus.gov/druginfo/meds/a601249.html)   Other longevity / comparison drugs mentioned Metformin — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a696005.html](https://medlineplus.gov/druginfo/meds/a696005.html) Sirolimus (Rapamycin) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a602026.html](https://medlineplus.gov/druginfo/meds/a602026.html)   Side-effect helper mentioned Ibuprofen (Advil) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a682159.html](https://medlineplus.gov/druginfo/meds/a682159.html)   Dementia meds mentioned Donepezil (Aricept) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a697032.html](https://medlineplus.gov/druginfo/meds/a697032.html) Amantadine — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a682064.html](https://medlineplus.gov/druginfo/meds/a682064.html)   Lab markers mentioned Hemoglobin A1C (HbA1c) test — MedlinePlus lab test: [https://medlineplus.gov/lab-tests/hemoglobin-a1c-hba1c-test/](https://medlineplus.gov/lab-tests/hemoglobin-a1c-hba1c-test/) Insulin in blood test — MedlinePlus lab test: [https://medlineplus.gov/lab-tests/insulin-in-blood/](https://medlineplus.gov/lab-tests/insulin-in-blood/)   People referenced (where the claims were mentioned) Huberman Lab (Dr. Andrew Huberman) — site: [https://www.hubermanlab.com/](https://www.hubermanlab.com/) Clip about low-dose tadalafil (2.5–5mg) — X post: [https://x.com/tbpn/status/2022350426394534334](https://x.com/tbpn/status/2022350426394534334) Bryan Johnson (Blueprint) — site: [https://blueprint.bryanjohnson.com/](https://blueprint.bryanjohnson.com/) Dr. David Sinclair (Harvard profile) — site: [https://sinclair.hms.harvard.edu/people/david-sinclair](https://sinclair.hms.harvard.edu/people/david-sinclair)   Show Notes   00:00 Welcome to the Hart2Heart Podcast. 01:56 What Cialis Is: PDE5 Inhibition, cGMP & Nitric Oxide Explained 03:43 Approved Uses & Origin Story: Pulmonary Hypertension, ED, and BPH 05:33 Why Cialis Over Viagra: 36-Hour Half-Life & 24/7 Vascular Benefits 06:52 Vascular Aging 101: Endothelium, Perfusion, and Why It Drives Disease 11:14 What the Human Data Shows: Observational Evidence for Mortality, CVD & Dementia 13:04 Mechanisms Deep Dive: Heart Protection, Heart Failure, and Anti-Atherosclerosis 15:02 Cialis for Diabetics: Lowering A1C and Improving Insulin Sensitivity 16:21 Brain Effects: Blood–Brain Barrier, Neurovascular Coupling & Dementia Potential 18:21 Safety, Who Should Avoid It, and Daily Longevity Dosing (2.5–5 mg) + Wrap-Up   The Hart2Heart podcast is hosted by family physician Dr. Michael Hart, who is dedicated to cutting through the noise and uncovering the most effective strategies for optimizing health, longevity, and peak performance. This podcast dives deep into evidence-based approaches to hormone balance, peptides, sleep optimization, nutrition, psychedelics, supplements, exercise protocols, leveraging sunlight, and de-prescribing pharmaceuticals — using medications only when absolutely necessary. Beyond health science, we explore the intersection of public health and politics, exposing how policy decisions shape our health landscape and what actionable steps people can take to reclaim control over their well-being. Guests range from out-of-the-box thinking physicians such as Dr. Casey Means (author of "Good Energy") and Dr. Roger Sehult (Medcram lectures) to public health experts such as Dr. Jay Bhattacharya (Director of the National Institutes of Health (NIH) and Dr. Marty Mckary  (Commissioner of the Food and Drug Administration (FDA) and high-profile names such as  Zuby and Mark Sisson (Primal Blueprint and Primal Kitchen). If you're ready to take control of your health and performance, this podcast is for you.We cut through the jargon and deliver practical, no-BS advice that you can implement in your daily life, empowering you to make positive changes for your well-being.   Connect with Dr. Mike Hart Instagram: @drmikehart Twitter: @drmikehart Facebook: @drmikehart

Long considered a transit route, Pakistan is now emerging as a major hub for both drug production and consumption. This shift follows the upheaval triggered by the Taliban's return to power in Afghanistan in 2021.

SWAT Team STORMS Court Mid Game After Paul George's Drug Confession NBA Suspended

Detectives Benson and Stabler are called in when an infant dies after drinking baby formula mixed with cocaine. When more tainted formula is found in the home of Derek Pfeiffer, Fin and Munch suspect he's been smuggling in the liquid coke from Mexico. But things take a turn when IAB takes over the investigation and Pfeiffer is murdered. Cragen strong-arms Tucker to let Elliot go undercover and infiltrate the drug ring. It's managed by a dirty cop, and when a sting goes sideways, Stabler is forced to shoot him in self-defense.  Still looking for the kingpin, Benson and Cragen learn Pfeiffer never had a baby. His wife had been taking her infant nephew to Mexico as a cover to smuggle the formula.  Now the kingpin is tying up loose ends by killing Mrs. Pfeiffer and all the other mothers who rented their babies as drug mules.We're talking about Special Victims Unit season 4 episode 12 "Risk." Our guest is Mel Barrett from the "Something's Off" and "The Inbetween" podcasts.Some inspiration for this episode comes from the 1992 case of NYPD officer Michael Dowd. For exclusive content from Kevin and Rebecca, sign up on Patreon.This show was recorded in The Caitlin Rogers Project Studio. Click to find out more. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

California voters were promised $370 million in cannabis tax revenue for drug prevention and youth treatment through Prop 64. So why are tens, even hundreds of millions flowing through activist nonprofits and voter registration efforts instead? In this episode, we break down what Prop 64 promised… where the money is actually going… and why many critics say “drug prevention” has turned into a political slush fund wrapped in good intentions. We unpack: How cannabis tax dollars are allocated The role of The Center at Sierra Health Foundation's Elevate Youth program Why NGOs tied to political organizing are receiving prevention funds What this says about accountability, governance, and cultural leadership And most importantly, what this means for men who choose to live clear-headed, sober-minded, and awake. Because sobriety isn't just about quitting alcohol.It's about discernment.It's about responsibility.It's about seeing straight in a culture that profits off distraction. Join the Victory Circle our free digital men's community and surround yourself with high-performing men living alcohol-free. Sober minds see straight… and straight calls make change. Sober Executive Performance Reset: A 12 Week Private Coaching Experience - APPLY HERE https://www.thatsoberguy.com/coaching Invite Shane to Speak - https://www.thatsoberguy.com/speaking Join “The Victory Circle”, our FREE Sober Guy Mens Community at https://www.thatsoberguy.com/offers/SvjjuEQ2/checkout Check out Shanes New Book, Sober Guy How Do I - https://a.co/d/81ZIgtE Tired of Drinking? Try Our 30 Day Quit Drinking Dude Challenge! - https://www.thatsoberguy.com/quit-drinking-alcohol-for-30-days For More Resources go to http://www.ThatSoberGuy.com Follow us on LinkedIn - https://www.linkedin.com/in/shane-ramer-7534bb257/ Follow us on Instagram @ThatSoberGuyPodcast Follow us on YouTube - https://www.youtube.com/thatsoberguypodcast  Follow us on X @ThatSoberGuyPod https://caldoge.rhetor.ai/prop-64 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The U.S. military conducted airstrikes on three alleged narco-trafficking boats, resulting in the deaths of 11 male narco-terrorists.See omnystudio.com/listener for privacy information.

WMAL GUEST: SARA CARTER (Director of the Office of National Drug Control Policy) on hosting a White House roundtable with social media companies to combat illicit drug sales targeting children. WEBSITE: ONDCP Official Page SOCIAL MEDIA: X.com/SaraCarterDC READ: Sara Carter Confirmed as National Drug Czar Where to find more about WMAL's morning show: Follow Podcasts on Apple Podcasts, Audible, and Spotify Follow WMAL's "O'Connor and Company" on X: @WMALDC, @LarryOConnor, @JGunlock, @PatricePinkfile, and @HeatherHunterDC Facebook: WMALDC and Larry O'Connor Instagram: WMALDC Website: WMAL.com/OConnor-Company Episode: Wednesday, February 18, 2026 / 8 AM HourSee omnystudio.com/listener for privacy information.

In the 8 AM Hour: Larry O’Connor and Bethany Mandel discussed: WMAL GUEST 8:05 AM - INTERVIEW - SARA CARTER - Director of the Office of National Drug Control Policy SOCIAL MEDIA: https://x.com/SaraCarterDC TOPIC: ROUNDTABLE TODAY AT WHITE HOUSE: Drug Czar Hosts Roundtable Discussion at the White House About Combatting Illicit Drug Trafficking on Social Media Bethany makes a good case for why the Weight loss drug hype is not a bad thing Meet Eileen Gu, an American competing for China at Winter Olympics CRITTER NEWS: Dog on the course at Olympic skiing event Where to find more about WMAL's morning show: Follow the Show Podcasts on Apple podcasts, Audible and Spotify. Follow WMAL's "O'Connor and Company" on X: @WMALDC, @LarryOConnor, @Jgunlock, @patricepinkfile, @bethanyshondark and @heatherhunterdc. Facebook: WMALDC and Larry O'Connor Instagram: WMALDC Show Website: https://www.wmal.com/oconnor-company/ How to listen live weekdays from 5 to 9 AM: https://www.wmal.com/listenlive/ Episode: Wednesday, February 18, 2026 / 8 AM Hour See omnystudio.com/listener for privacy information.

County alleges unlawful price inflation.

Use of gabapentin with or without a prescription in substance use treatment settings: A national analysis of urine drug testing data, 2016–2023  Drug and Alcohol Dependence Gabapentin prescriptions have increased due to off-label use, including managing withdrawal/comorbidities in substance use disorder (SUD) treatment, despite gaps in evidence bases and corresponding increases in nonmedical use. This retrospective, serial cross-sectional study sought to identify trends in gabapentin use with and without a prescription in SUD treatment settings.  Researchers found that gabapentin prescribing significantly increased in SUD treatment settings despite a lack of strong evidence bases for its utility. While rates of gabapentin use outside a prescription were nearly double that for prescribed use, this appears to be decreasing over time. Polysubstance use and potential gaps in multimorbidity care may contribute to the use of gabapentin without a prescription.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

According to a King's College London report published last week the UK has been underreporting nitazene-related deaths by up to a third. Why has the UK become a hotspot for the extremely potent opioid?Writer: Jonathan LewisProducer: Jonathan LewisHost: Ada BaruméEpisode photography: Joe MeeExecutive Producer: Matt Russell Hosted on Acast. See acast.com/privacy for more information.

See Adam on tour https://theadamfriedland.show/pages/tour -- JOIN THE FRIEDLAND FAMILY FOUNDATION / PREMIUM SUBSCRIPTION: https://www.youtube.com/@TheAdamFriedlandShow/join -- Patreon: https://www.patreon.com/cw/TheAdamFriedlandShow -- Buy our merch!: https://theadamfriedland.show/collections/new -- The Adam Friedland Show - Season Two Episode 35 | Clavicular X: https://x.com/adam_talkshow Instagram: https://www.instagram.com/theadamfriedlandshow TikTok: https://www.tiktok.com/@adamfriedlandshowclips YouTube: Subscribe to @TheAdamFriedlandShow here: https://www.youtube.com/c/TheAdamFriedlandShow Subscribe to @TAFSClips here: https://www.youtube.com/@tafsclips -- Go to TempoMeals.com/TAFS to get 60% off your first box Head to livemomentous.com and use promo code TAFS for up to 35% off your first order — #adamfriedland #theadamfriedlandshow #Clavicular

In this episode of The Performance Medicine Show, Dr. Rogers answers YOUR health and wellness questions! Check out our online vitamin store:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠https://performancemedicine.net/shop/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sign up for our weekly newsletter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://performancemedicine.net/doctors-note-sign-up/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

This episode is a conversation with John Walsh, WOLA's director for Drug Policy and the Andes, about the ongoing U.S. military attacks on civilian boats in the Caribbean and Pacific Oceans. When Walsh and host Adam Isacson recorded this episode, on February 13, 2026, 35 attacks had killed at least 131 people since September 2, 2025—an average of four killings every five days—and another attack later that day killed 3 more people. Walsh and Isacson just published a WOLA commentary, "The Boat Strikes are Still Happening: Five Things You Need to Know," warning against the dangerous normalization of extrajudicial executions carried out directly by the U.S. military. Five months into this campaign, the strikes are fading from public attention despite their illegality. Media coverage has dwindled from the intense scrutiny of September and the revelations about "double tap" strikes on survivors in December to a trickle of stories. This normalization poses dangers: the justifications being used could extend to other victims in other contexts, and elements of the U.S. military appear to be accepting unlawful orders. There is no congressional authorization for military force against drug traffickers. Under international law, the United States is not engaged in an armed conflict with drug cartels—designating groups as foreign terrorist organizations does not confer wartime authorities. From a drug policy perspective, Walsh argues these strikes are futile. After five months, there is no evidence of a disruption to cocaine supplies. Drug trafficking organizations are highly adaptive, with alternative routes readily available. The administration's own recognition that traditional interdiction didn't work led them to this extreme escalation, but killing traffickers at sea will not fundamentally alter market dynamics driven by constant demand and enormous profits under prohibition. The boat strikes, if "normalized," could prepare the ground for grave future outcomes. The administration's willingness to label anonymous victims as "narcoterrorists" creates a template for applying similar labels to domestic opponents—something already visible in the characterization of ICE critics and the victims of Chicago and Minneapolis shootings as "domestic terrorists." Walsh notes that President Trump has expressed his desire to deploy military forces against "the enemy within" on U.S. streets, and the compliance of Southern Command with these illegal orders suggests obedience to the president over the Constitution. "The illegality is not a bug, it's a feature," Walsh concludes. Walsh concludes by emphasizing the importance of litigation on behalf of victims' families, the moral voice of faith leaders, and continued media attention to prevent normalization. These strikes, he argues, are not a peripheral story but central to the administration's declared strategy of dominating the Western Hemisphere through coercion.

These are some truly harrowing stories from legal substances that are even sold in gas stations! A big thank you to Someone That's NoOne for lending his voice for a few stories. Be sure to check his channel out!

AP correspondent Ed Donahue reports more alleged drug cartel boats have been targeted by the U.S.

Heather's Powerful Survivor's Story: Overcoming Narcissistic Abuse, Domestic Violence, Drug Addiction & Attempted Murder – Part 1 of 2 Trigger Warning / Content Disclaimer: This raw, true survivor story contains explicit details of heavy drug use, narcissistic abuse, physical violence, and attempted murder. Listener discretion is strongly advised. Heather bravely steps forward to share her unfiltered journey in this two-part series. Many assume drugs were the root of her nightmare — but Heather makes one thing crystal clear: drugs do not cause abuse; they only make abuse far worse. She knows this truth from painful, firsthand experience. In Part 1, you'll hear about: • Growing up with narcissistic parents who shaped her early trauma • A string of emotionally and physically abusive boyfriends • Her dangerous marriage to a violent ex-husband who nearly ended her life It's nothing short of a miracle that Heather is still here today. Despite the years of manipulation, control, beatings, and terror, Heather fought her way back to the strong, authentic woman she was always meant to be. Her greatest lifeline? Herself — and her son, Abe. Together, this mother-son duo refused to give up. They saved each other, broke the cycle, and are now both thriving in freedom and healing. If you or someone you love is trapped in narcissistic abuse, domestic violence, toxic relationships, or battling addiction-fueled trauma, Heather's story will give you hope, validation, and proof that recovery and freedom are possible. Perfect for anyone searching: • Narcissistic abuse recovery stories • Domestic violence survivor interviews • Escaping abusive relationships with children • Healing from narcissistic parents • Drug addiction and intimate partner violence • Real stories of surviving attempted murder

This is part two, the final part of a two-part story with Heather. Trigger Warning / Content Disclaimer: This raw, true survivor story contains explicit details of heavy drug use, narcissistic abuse, physical violence, and attempted murder. Listener discretion is strongly advised. Heather bravely steps forward to share her unfiltered journey in this two-part series. Many assume drugs were the root of her nightmare — but Heather makes one thing crystal clear: drugs do not cause abuse; they only make abuse far worse. She knows this truth from painful, firsthand experience. In Part 2, you'll hear about: • Growing up with narcissistic parents who shaped her early trauma • A string of emotionally and physically abusive boyfriends • Her dangerous marriage to a violent ex-husband who nearly ended her life It's nothing short of a miracle that Heather is still here today. Despite the years of manipulation, control, beatings, and terror, Heather fought her way back to the strong, authentic woman she was always meant to be. Her greatest lifeline? Herself — and her son, Abe. Together, this mother-son duo refused to give up. They saved each other, broke the cycle, and are now both thriving in freedom and healing. If you or someone you love is trapped in narcissistic abuse, domestic violence, toxic relationships, or battling addiction-fueled trauma, Heather's story will give you hope, validation, and proof that recovery and freedom are possible. Perfect for anyone searching: • Narcissistic abuse recovery stories • Domestic violence survivor interviews • Escaping abusive relationships with children • Healing from narcissistic parents • Drug addiction and intimate partner violence • Real stories of surviving attempted murder

In this week's Stansberry Investor Hour, Dan and John Engel welcome Dave Lashmet to the show. Dave is the editor of Stansberry Venture Technology, an advisory that takes a "venture capitalist" look at the market. Dave scours the market looking for little-known small-cap companies that are potentially producing the next wonder drug or technology.   Dave kicks things off by discussing the first of three biopharmaceutical companies he's sharing that have monopolies in weight-loss drugs. He starts by showing how drugs gain their monopolies via patents, giving them "economic exclusivity." While companies might be targeting the same patients, the patents influence how they're being treated. The first company gains an edge by not only targeting folks suffering from obesity, but also by treating those with Type 2 diabetes. Dave also explains the contrast in mentality between the U.S. and other countries regarding obesity being preventable. And he provides info showing how obesity is a "slippery slope" and shares that a study found that participants who got off the drug gained back the weight they lost before. (0:00)   Next, Dave sums up how the first company has cleared all of the risks and expenses from clinical trials, while a close competitor still has to get past its trials due to unknown side effects. When asked about why folks would stay on a weight-loss pill for life, Dave points to how our culture has drastically changed over the years, from actively working on farms to passively working in cubicles. These drugs help balance out the resulting shift. Dave then transitions into the next company that has a drug that focuses on fatty liver disease. He explains how this distinction helps the company gain its monopoly due to how irreplaceable livers are. And similar to the first company, this drug will have lifelong consumers. And the good news for investors is that its only competitor causes weight gain. (21:49)   Finally, Dave presents the final company that tackles weight loss by focusing on genetics. Unlike the first two companies, this one treats patients with an injectable drug rather than a pill. However, it zeroes in on our natural "hunger switch," suppressing the users' appetites. Right now, the company is only waiting to get past trials, which puts it at a disadvantage compared with the other two. But Dave still believes that because of how it works, it's still set to stand beside the two pills. (39:44)

Biopharmaceutical innovation is advancing at an unprecedented pace, yet many patients still face barriers to accessing new medicines. In this episode of Health Matters, John O’Brien, president and CEO of the National Pharmaceutical Council, speaks with Kristin Cahill about why policy, pricing and benefit design are increasingly shaping whether innovation reaches patients. O’Brien shares insights from his career spanning pharmaceutical companies, health plans and government, including his time as a senior drug pricing advisor during the first Trump administration. He explains why prescription drugs remain a focal point in cost debates, what policymakers often misunderstand about value, and how middlemen and misaligned incentives affect what patients pay at the pharmacy counter. The conversation also examines emerging approaches such as direct-to-patient models, most-favored-nation pricing and the early effects of the Inflation Reduction Act, highlighting potential benefits as well as risks to access and future innovation. For healthcare professionals, payers and marketers seeking clarity in a complex policy environment, this episode offers a grounded perspective on how to ensure medical breakthroughs translate into meaningful patient benefit. Listen to the full interview.See omnystudio.com/listener for privacy information.

Welcome to the Atomic Anesthesia podcast hosted by CRNA professor Dr. Rhea Temmermand and Co-Founder Sachi Lord. On this show, you'll hear clear, clinically grounded discussions designed for nurse anesthesia residents and CRNAs who want to feel more confident in complex pharmacology, physiology, and real-world anesthesia decision-making.⚠️ SIGN UP FOR OUR FREE NEWSLETTER: [NEWSLETTER SIGN-UP]In this episode:One-week launch countdown plus a behind-the-scenes tour of the new Atomic Anesthesia platform.Overview of current features: 150+ lessons, quiz builder with 2,000+ questions, and gamified learning with avatars, gems, and leaderboards.Breakdown of seven core pharmacology concepts to make drug questions predictable instead of pure memorization.Clinical-style thinking tips: using receptor logic, dose–response, onset, redistribution, protein binding, and context-sensitive half-time to anticipate drug behavior.

Support the show:https://www.paypal.me/Truelifepodcast?locale.x=en_USOne on One Video Call W/George https://tidycal.com/georgepmonty/60-minute-meetingI found footage of two octopi speaking in geometric patterns. Ran it throughlinguistic software. It flagged as LANGUAGE—the same patterns I'd been seeingon DMT for years. So I reverse-engineered their neurochemistry, attached it toa tryptamine, and learned to read the language my hallucinations have beenspeaking this entire time.LEXICON-7: the compound that hijacks your claustrum and teaches you exponentiallanguage. The mandalas aren't decoration—they're grammar. The geometry isn'tnoise—it's syntax. Seven dimensions. Cross-modal binding. Visual cortex wireddirectly to Broca's area.I took it in an art studio. The paintings started conjugating.I learned to respond.Now I can't stop reading. The world is written in a language I finallyunderstand, and it's beautiful and terrifying in exactly equal measure.Octopi have been doing this for 300 million years. Now, theoretically, so canyou.◯ ⟲ ⟲ ⟲ — One on One Video call W/George https://tidycal.com/georgepmonty/60-minute-meetingSupport the show:https://www.paypal.me/Truelifepodcast?locale.x=en_US

Along with no alcohol and no drugs, young people making their Confirmation pledges will now promise not to vape until they're 18 years old. For more on this Anton spoke to Bishop Michael Router of the Irish Bishop's Drug's.

In this week's Stansberry Investor Hour, Dan and John Engel welcome Dave Lashmet to the show. Dave is the editor of Stansberry Venture Technology, an advisory that takes a "venture capitalist" look at the market. Dave scours the market looking for little-known small-cap companies that are potentially producing the next wonder drug or technology.   Dave kicks things off by discussing the first of three biopharmaceutical companies he's sharing that have monopolies in weight-loss drugs. He starts by showing how drugs gain their monopolies via patents, giving them "economic exclusivity." While companies might be targeting the same patients, the patents influence how they're being treated. The first company gains an edge by not only targeting folks suffering from obesity, but also by treating those with Type 2 diabetes. Dave also explains the contrast in mentality between the U.S. and other countries regarding obesity being preventable. And he provides info showing how obesity is a "slippery slope" and shares that a study found that participants who got off the drug gained back the weight they lost before. (0:00)   Next, Dave sums up how the first company has cleared all of the risks and expenses from clinical trials, while a close competitor still has to get past its trials due to unknown side effects. When asked about why folks would stay on a weight-loss pill for life, Dave points to how our culture has drastically changed over the years, from actively working on farms to passively working in cubicles. These drugs help balance out the resulting shift. Dave then transitions into the next company that has a drug that focuses on fatty liver disease. He explains how this distinction helps the company gain its monopoly due to how irreplaceable livers are. And similar to the first company, this drug will have lifelong consumers. And the good news for investors is that its only competitor causes weight gain. (21:49)   Finally, Dave presents the final company that tackles weight loss by focusing on genetics. Unlike the first two companies, this one treats patients with an injectable drug rather than a pill. However, it zeroes in on our natural "hunger switch," suppressing the users' appetites. Right now, the company is only waiting to get past trials, which puts it at a disadvantage compared with the other two. But Dave still believes that because of how it works, it's still set to stand beside the two pills. (39:44)

See omnystudio.com/listener for privacy information.

Investigative reporter Nick McKenzie’s 2024 exposé of the criminal infiltration of the construction sector prompted a slew of investigations among governments and law enforcement agencies around the country.The conclusions of those investigations reveal the extent of that corruption, and its findings are damning - including that the CFMEU's conduct could have cost taxpayers $15 billion, and the Victorian government knew of the problems but did not fix the problem.Drug trafficking and shocking sexual exploitation of women on major infrastructure sites - are some of the other claims.Today Nick McKenzie on the serious questions the government has to answer.Subscribe to The Age & SMH: https://subscribe.smh.com.au/See omnystudio.com/listener for privacy information.

Investigative reporter Nick McKenzie’s 2024 exposé of the criminal infiltration of the construction sector prompted a slew of investigations among governments and law enforcement agencies around the country.The conclusions of those investigations reveal the extent of that corruption, and its findings are damning - including that the CFMEU's conduct could have cost taxpayers $15 billion, and the Victorian government knew of the problems but did not fix the problem.Drug trafficking and shocking sexual exploitation of women on major infrastructure sites - are some of the other claims.Today Nick McKenzie on the serious questions the government has to answer.Subscribe to The Age & SMH: https://subscribe.smh.com.au/See omnystudio.com/listener for privacy information.

In this episode, Alex Yampolsky, PharmD MBA, Chief Clinical Officer at MedServe, discusses how outdated medication management puts outpatient facilities at risk and how technology can prevent drug diversion, improve safety, and reduce administrative burden. He also shares career lessons from his path as a pharmacist turned healthcare entrepreneur.

The 23rd Big Sky Documentary Film Festival is underway in Missoula. The annual event celebrates nonfiction films and creators from around the world – including right here in Montana. MTPR's Austin Amestoy sat down with the filmmakers behind “Big Sky Falling,” a film about a web of Montana State University student athletes connected to a killing and drug dealing ring.

Send a text | I am your host, Neo Griot, and this is Episode 269 of the Rational Black Thought Podcast.  This week's title is a line Kanye dropped that still cuts like a scalpel:  “Drug dealer buy Jordans, crackhead buy crack / And a white man get paid off of all of that.” From “All Falls Down” on College Dropout.  And I'm starting there because it's not just a lyric. It's a diagnosis.  It's the economic machine in plain English: predation gets dressed up as “the market,” addiction gets criminalized, consumption gets celebrated, and the profits flow upward to people who never touch the poison. The street-level players get cages. The executives get quarterly bonuses. And everybody pretends this is just “personal responsibility” instead of a system engineered for extraction.  So that's the moral frame for today's episode: follow the incentives, follow the money, and don't let anyone replace analysis with fucking sermons. Intro: Quote of the Week: James Baldwin Unmasking the News: Democracy Watch: Bondi in Two Chambers: Same Shit“Energy Freedom” or Freedom From Accountability Seven Years for a Pastor Who Preyed on a Teen Isn't Justice. It's Barely a Slap on the Wrist Good News: David Steward Didn't Go Viral. He Went Vertical Bible Study with an Atheist: From Spirits to Sky-Daddies: How Religion Evolved When Humans Didn't Know What Was Going On Reflections and Call to Action: Closing/Outro:https://www.courthousenews.com/gop-leaders-split-on-bondis-use-of-lawmaker-epstein-files-search-history/https://apnews.com/article/green-energy-environment-trump-rollbacks-fact-check-208382e5fb17f9ec6831831f50f7232ehttps://www.theguardian.com/us-news/2026/feb/12/louisiana-pentecostal-pastor-molestation-sentencehttps://www.thetallcotton.com/david-l-steward-world-wide-technology/Power Concedes Nothing without a Demand...

The science says no, at least not in the athletic sense. But the psychic benefits can be large — just ask former N.F.L. star Ricky Williams. He says athletes should consider cannabis a healing drug, not a party drug. Even the N.F.L. is starting to agree. (Part two of a two-part series.) SOURCES:Angela Bryan, professor, associate chair for faculty development in the department of psychology and neuroscience at the University of Colorado, Boulder.Ricky Williams, former N.F.L. running back, founder of Highsman. RESOURCES:"Using A Lab On Wheels To Study Weed From Dispensaries," by Science Friday (2024)."Exercise-induced euphoria and anxiolysis do not depend on endogenous opioids in humans," by Michael Siebers, Sarah Biedermann, Laura Bindila, Beat Lutz, and Johannes Fuss (Psychoneuroendocrinology, 2021)."Endocannabinoids mediate runner's high," by Sudhakaran Prabakaran (Science Signaling, 2015)."Cannabis and Exercise Science: A Commentary on Existing Studies and Suggestions for Future Directions," by Angela Bryan, Arielle Gilman, and Kent Hutchison (Sports Medicine, 2015).Run Ricky Run, documentary (2010). EXTRAS:"Is America Switching from Booze to Weed?" series by Freakonomics Radio (2024). Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Pink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs discuss the US Food and Drug Administration's controversial decision to refuse to file Moderna's mRNA-1010 seasonal influenza vaccine candidate, including the unusual public airing of grievances (2:10), the changing issues sparking RTF actions (5:51), the uncertainty created by the decision and how vaccine sponsors should react going forward (16:54). More On These Topics From The Pink Sheet Moderna Cites Changing Advice As US FDA Refuses To File Flu Vaccine BLA: https://insights.citeline.com/pink-sheet/vaccines/moderna-cites-changing-advice-as-us-fda-refuses-to-file-flu-vaccine-bla-SRLIEHHMOFEWFPTLYJCXFIF5FM/ HHS Defends US FDA Refusal To File Moderna's Flu Vaccine: https://insights.citeline.com/pink-sheet/vaccines/hhs-defends-us-fda-refusal-to-file-modernas-flu-vaccine-NULTQ6P6R5C6DDXZFMZROE3HRU/

⭐ This is a featured encore of one of our most downloaded STR Investing episodes. Originally released on June 6th 2024, this episode continues to inspire investors to think bigger and execute smarter.In this episode of the STR Investing Podcast, co-host Taylor Jones welcomes Tyann Marcink, the "Queen of Guest Experience," to share how she transformed a $55,000 drug house into a $1.5 million short-term rental success story.Tyann walks through: • How she identified hidden potential others overlooked • The renovation strategy that unlocked massive value • The guest experience upgrades that drive revenue • Lessons learned from turning a distressed property into a high-performing assetThis episode proves that creative vision, execution, and guest-focused design can completely change the trajectory of a deal.If you're serious about scaling your short-term rental portfolio, this is one to study.__Episode Sponsored By:STR SearchSTR Search is the industry leading property finder service. They've helped investors acquire over 215 profitable STRs across the US. If you'd like the data professionals to help you find your next STR, reach out to STRsearch.com

This seems like a trap.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Driver accused of intentionally hitting group outside a California Safeway including Little Leaguers selling beef jerky , Olympic athlete wins bronze medal and then publicly shames himself for cheating on his girlfriend, Drug dealer who was inspired by 'Home Alone' rigged his house with booby traps

-Rob reacts in horror as on-the-ground footage shows California's “homeless industrial complex” reviving fentanyl users with Narcan—only to hand them fresh needles so the cycle can continue. -Hilary Fordwich, joining via the Newsmax Hotline, breaks down how the Epstein fallout rattles the British royal family, sidelines Prince Andrew, and puts Prime Minister Keir Starmer in a political lose-lose as Prince William quietly cleans house. Today's podcast is sponsored by : RELIEF FACTOR - You don't need to live with aches & pains! Reduce muscle & joint inflammation and live a pain-free life by visiting http://ReliefFactor.com  QUINCE CLOTHING - Refresh your wardrobe with Quince.  Go to http://Quince.com/NEWSMAX for free shipping on your order and 365-day returns. BIRCH GOLD - Protect and grow your retirement savings with gold. Text ROB to 98 98 98 for your FREE information kit! To call in and speak with Rob Carson live on the show, dial 1-800-922-6680 between the hours of 12 Noon and 3:00 pm Eastern Time Monday through Friday…E-mail Rob Carson at : RobCarsonShow@gmail.com Musical parodies provided by Jim Gossett (http://patreon.com/JimGossettComedy) Listen to Newsmax LIVE and see our entire podcast lineup at http://Newsmax.com/Listen Make the switch to NEWSMAX today! Get your 15 day free trial of NEWSMAX+ at http://NewsmaxPlus.com Looking for NEWSMAX caps, tees, mugs & more? Check out the Newsmax merchandise shop at : http://nws.mx/shop Follow NEWSMAX on Social Media:  -Facebook: http://nws.mx/FB  -X/Twitter: http://nws.mx/twitter -Instagram: http://nws.mx/IG -YouTube: https://youtube.com/NewsmaxTV -Rumble: https://rumble.com/c/NewsmaxTV -TRUTH Social: https://truthsocial.com/@NEWSMAX -GETTR: https://gettr.com/user/newsmax -Threads: http://threads.net/@NEWSMAX  -Telegram: http://t.me/newsmax  -BlueSky: https://bsky.app/profile/newsmax.com -Parler: http://app.parler.com/newsmax Learn more about your ad choices. Visit megaphone.fm/adchoices

This seems like a trap. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

With a carnivore diet, Phillip improved over 30 years of skin issues including eczema, severe plaque psoriasis, palm and plantar psoriasis, and scalp psoriasis. Phillip also improved his pre-diabetes. Instagram: https://www.instagram.com/mrphillipwin/ TikTok: https://www.tiktok.com/@mrphillipwin X: https://x.com/MrPhillipWin Timestamps: 00:00 Diet's role in autoimmune health 04:49 Topical steroid concerns in dermatology 09:49 Medication concerns and side effects 12:43 Psoriasis treatment self-discovery 14:49 Persistence with psoriasis treatment 17:49 Carnivore diet benefits and downsides 20:19 Health concerns and cultural food 24:02 Dairy tolerance and eczema 29:28 Biologics push for psoriasis treatment 31:11 Drug cycle and muscle loss 35:01Overcoming chronic illness Join Revero now to regain your health: https://revero.com/YT Revero.com is an online medical clinic for treating chronic diseases with this root-cause approach of nutrition therapy. You can get access to medical providers, personalized nutrition therapy, biomarker tracking, lab testing, ongoing clinical care, and daily coaching. You will also learn everything you need with educational videos, hundreds of recipes, and articles to make this easy for you. Join the Revero team (medical providers, etc): https://revero.com/jobs ‪#Revero #ReveroHealth #shawnbaker  #Carnivorediet #MeatHeals #AnimalBased #ZeroCarb #DietCoach  #FatAdapted #Carnivore #sugarfree Disclaimer: The content on this channel is not medical advice. Please consult your healthcare provider.

What would you do if your pharmacist came to you and said "I'd like to get a plan together to get you on less medication?" That's what host Steve Cutler and guest Brian Lunt discuss in Episode 185 of The Evolved Man.  Utilizing therapeutic lifestyle changes along with medication Brian and his team are making headways in the healthcare space.  Join Steve and Brian for a conversation about how therapeutic lifestyle changes can significantly reduce your need for medication and how having a collaborative conversation with your health care providers can move you in a positive way towards better health and healing.  Connect with Brian HERE  Follow Us! Newsletter Instagram  X  The Evolved Man is produced by Steve Cutler and EVOLVE International, LLC, all rights reserved.  This podcast is for entertainment purposes only.  Always consult with a qualified medical professional before starting, changing or adjusting any exercise, health or nutrition protocols. 

Synopsis: At JPM 2026 in San Francisco, Alok Tayi welcomes Michelle Werner, CEO of Alltrna, to Biotech 2050 for a powerful conversation at the intersection of personal mission, platform biology, and rare-disease drug development. Michelle traces her two-decade career across Bristol Myers Squibb, AstraZeneca, and Novartis—and the moment everything changed when her child was diagnosed with a rare disease. That experience led her to Alltrna and its pioneering engineered tRNA platform, designed to correct nonsense mutations across hundreds—potentially thousands—of genetic disorders with a single therapeutic approach. Together, Alok and Michelle explore how tRNAs work, why “stop-codon disease” could redefine rare-disease classification, and how basket trials borrowed from oncology may accelerate development. They dive into delivery strategy, portfolio expansion into CNS and muscle disorders, regulatory innovation, and how AI is reshaping molecular design—offering a rare look at what it takes to build a first-in-class modality from the ground up. Biography: Michelle is a seasoned pharmaceutical executive with more than 20 years in the industry spanning commercial and research & development (R&D) responsibilities. Prior to Alltrna, Michelle served as Worldwide Franchise Head, Solid Tumors at Novartis Oncology, where she was responsible for delivering the disease area strategies across multiple tumors and led business development efforts resulting in a doubling of long-term portfolio value for the franchise. Previous to Novartis, Michelle was a senior leader at AstraZeneca and as Global Franchise Head in Hematology, she was critical in launching multiple indications worldwide for CALQUENCE®. Prior to this, Michelle was Head of US Oncology, where she led the business through dramatic growth in both team and revenue through eight-plus product launches. Previous to AstraZeneca, Michelle was with Bristol-Myers Squibb for 10 years in various positions of increasing responsibility including roles in sales, marketing, and market access in the US and UK, and above market in Europe (based in France) and global almost exclusively in oncology. Michelle started her professional career in R&D, working hands-on with patients at the Oncology Clinical Trials Unit at Harvard Medical School before moving into industry in clinical operations. Outside of her corporate responsibilities, Michelle is a wife and mother to three children and is a member of the rare disease community. She is currently serving a Board appointment for the non-profit organization Rare Disease Renegades, a purpose that fuels her passions both personally and professionally.

Britain and China both saw the opium crisis clearly enough to know it would end in disaster. Each believed it understood the situation, and the other, well enough to keep events from spinning out of control. And yet... it happened anyway.Time Period Covered:Late 1839 – April 1840 Major Historical Figures: The Qing Empire:The Daoguang Emperor (Aisin-Gioro Minning) [r. 1820–1850]Lin Zexu, Imperial Commissioner and Governor-General of Huguang [1785–1850] The British Empire:Queen Victoria [r. 1837–1901]Henry John Temple, 3rd Viscount Palmerston, Foreign Secretary [1784–1865]Charles Elliot, Chief Superintendent of British Trade in China [1801–1875]William Gladstone, Member of Parliament [1789–1898]Sir James Graham, Member of Parliament [1792–1861] Major Sources Cited:Platt, Stephen R. Imperial Twilight: The Opium War and the End of China's Last Golden AgeLovell, Julia. The Opium War: Drugs, Dreams and the Making of ChinaFairbank, John K. Trade and Diplomacy on the China CoastHansard's Parliamentary Debates, 1840 Learn more about your ad choices. Visit megaphone.fm/adchoices

In this raw and unforgettable episode, Virginia street legend Pretty Tony sits down to tell his life story — from being introduced to crack at a young age, to becoming one of the most prolific cocaine cooks in Virginia history, to growing up alongside future rap superstars like Pharrell and the Clipse. Pretty Tony breaks down how he perfected the infamous “mix” that made him the go-to hood chemist, what it was like cooking bricks in kitchens for kingpin-level dealers, and how violence, robberies, torture, and street politics shaped his reality as a teenager. He also shares near-death experiences, including being shot in the face, wild encounters with rip crews, and seeing close friends and family fall to the game. This episode dives deep into: -Learning to cook crack at a young age -Becoming the neighborhood “hood chef” -Growing up with Pharrell, Pusha T, and Malice -Virginia's hidden kingpin era -Drug droughts, cartel-style tactics, and street economics -Surviving shootouts, robberies, and betrayal A brutally honest look at the streets, the music, and the thin line between fame and prison. Go Support Tony! Book: https://a.co/d/036MGUqH Merch: https://shop.app/m/w53xak0gbe This Episode Is #Sponsored By The Following: Prizepicks! Visit https://prizepicks.onelink.me/LME0/CONNECT and use code CONNECT and get $50 in lineups when you play your first $5 lineup! Rocket Money! Let Rocket Money help you reach your financial goals faster. Join at https://rocketmoney.com/connect Join The Patreon For Bonus Content! https://www.patreon.com/theconnectshow 00:00 From the Trap House: Pretty Tony's Origins 06:35 Family Ties & Street Influence 13:33 Virginia's Crack Era: The Rise of the Street Game 21:05 This Episode Is Sponsored By PrizePicks 22:01 Family, Cousins, and Murderers 32:39 The Art of Cooking: Becoming the Hood Chef 40:03 Mastering the Mix: Cracking the Recipe 45:00 The Music Connection 47:24 This Episode Is Sponsored By Rocket Money 48:33 Links to Pharrell, Clipse, and the Scene 53:32 Hustling & Robbery Crews – The Risk and Respect 01:03:21 Rising Profits and Street Networking 01:16:31 High Stakes: Plug Connections & Expanding Operations 01:31:22 Caught in the Crosshairs: The Deadly Setup 01:46:09 Surviving the Hit: Aftermath and Transformation 01:55:00 Getting Out the Game & The Virginia Scene 02:01:47 Legacies, The Music Stardom, and Moving On 02:04:27 Reflecting on Regret, Survival & The Future Learn more about your ad choices. Visit podcastchoices.com/adchoices

Can a “miracle” weight-loss drug really slow aging? Guest host Cheryl Burke dives in with Dr. Jesse Mills to expose the shocking truth about GLP-1s, testosterone, sugar addiction, and the wellness myths doctors.See omnystudio.com/listener for privacy information.

Can a “miracle” weight-loss drug really slow aging? Guest host Cheryl Burke dives in with Dr. Jesse Mills to expose the shocking truth about GLP-1s, testosterone, sugar addiction, and the wellness myths doctors.See omnystudio.com/listener for privacy information.

------------------- Watch This episode & more on YouTube! Connect With Us: @GoodMoms_BadChoices @TheGoodVibeRetreat @Good.GoodMedia @WatchErica @Milah_Mapp ------------------------------------------ PATREON Catch up with us over at Patreon and get all our Full visual episodes, bonus content & early episode releases. Submit your advice questions, anonymous secrets or vent about motherhood anonymously! Submit your questionsSee omnystudio.com/listener for privacy information.

When a son discovers that the man who raised him is capable of unimaginable harm, he is forced to become a whistleblower against his own father, risking his family, his identity, and everything he once believed to be true. Today's episode featured Kai Zen Bickle. To find out more about the legislation drafted with Child USA to close jurisdictional loopholes, specifically to ensure that evidence of sexual crimes committed against children on foreign soil can be brought back and used in U.S. courts, preventing perpetrators from escaping accountability by abusing international boundaries, please visit: https://childusa.org/law/ Producers: Whit Missildine, Andrew Waits, Jason Blalock Content/Trigger Warnings: Child sexual abuse, Sexual assault, Rape, Statutory rape, Grooming, Drug-facilitated sexual assault, Incest (sexual exploitation by a parent), Emotional abuse, Gaslighting, Psychological manipulation, Sexual exploitation, Coercion, Trauma, Dissociation, Moral injury, Whistleblower retaliation, Family betrayal, explicit language Social Media:Instagram: @actuallyhappeningTwitter: @TIAHPodcast Website: thisisactuallyhappening.com Website for Andrew Waits: andrdewwaits.comWebsite for Jason Blalock: jasonblalock.com Support the Show: Support The Show on Patreon: patreon.com/happening Wondery Plus: All episodes of the show prior to episode #130 are now part of the Wondery Plus premium service. To access the full catalog of episodes, and get all episodes ad free, sign up for Wondery Plus at wondery.com/plus Shop at the Store: The This Is Actually Happening online store is now officially open. Follow this link: thisisactuallyhappening.com/shop to access branded t-shirts, posters, stickers and more from the shop. Transcripts: Full transcripts of each episode are now available on the website, thisisactuallyhappening.com Intro Music: “Sleep Paralysis” - Scott VelasquezMusic Bed: Music To Air (MTA) - Houses ServicesIf you or someone you know is struggling with the effects of trauma or mental illness, please refer to the following resources: National Suicide and Crisis Lifeline: Text or Call 988 National Alliance on Mental Illness: 1-800-950-6264National Sexual Assault Hotline (RAINN): 1-800-656-HOPE (4673) See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.